Clinical Trial Details
| Trial ID: | L0686 |
| Source ID: | JPRN-UMIN000001587 |
| Associated Drug: | Olmesartan |
| Title: | |
| Acronym: | -- |
| Status: | -- |
| Study Results: | No Results Available |
| Results: | -- |
| Conditions: | Non-alcoholic steatohepatitis |
| Interventions: | administration of olmesartan (40mg daily) in 24 weeks.<br>administration of telmisartan (40mg daily) in 24 weeks.<br>administration of amlodipine (7.5mg daily) in 24 weeks. |
| Outcome Measures: | Before and after 6 months of medication to nonalcoholic statohepatitis (NASH) patients, we assessed liver lipid-metabolite alteration for use minute lipid analyzer: LipoSEARCH, hepatic histologic features,and AGTR1 gene polymorphisms.To measure the factors about NASH progressive marker as glucose and lipid metabolite, oxidative stress, visceral/subcutaneous fat area,liver TG content. |
| Sponsor/Collaborators: | Yokohama City University Hospital |
| Gender: | All |
| Age: | 20years-old80years-old |
| Phases: | Not selected |
| Enrollment: | 60 |
| Study Type: | Interventional |
| Study Designs: | Parallel Randomized |
| Start Date: | 25/12/2008 |
| Completion Date: | -- |
| Results First Posted: | -- |
| Last Update Posted: | 2 April 2019 |
| Locations: | Japan |
| URL: | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001825 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| D541 | Olmesartan | Chemical drug | DB00275 | -- | -- | Under clinical trials | Details |
| D080 | Citrulline | Chemical drug | DB00155 | -- | -- | Under clinical trials | Details |
| D094 | Cysteamine | Chemical drug | DB00847 | GSS stimulant | Renal drug | Under clinical trials | Details |
| D095 | Cysteamine bitartrate | Chemical drug | DB00847 | -- | -- | Under clinical trials | Details |
| D360 | Telmisartan | Chemical drug | DB00966 | PPARG partial agonist | Improve insulin resistance | Under clinical trials | Details |